Sarissa Consulting LLC Global Blood Therapeutics, Inc. Transaction History
Sarissa Consulting LLC
- $96.9 Million
- Q3 2022
A detailed history of Sarissa Consulting LLC transactions in Global Blood Therapeutics, Inc. stock. As of the latest transaction made, Sarissa Consulting LLC holds 26,000 shares of GBT stock, worth $0. This represents 1.83% of its overall portfolio holdings.
Number of Shares
26,000Holding current value
$0% of portfolio
1.83%Shares
1 transactions
Others Institutions Holding GBT
# of Institutions
8Shares Held
288KCall Options Held
0Put Options Held
0-
Roosevelt Investment Group LLC147KShares$00.72% of portfolio
-
Jefferies Group LLC New York, NY46.3KShares$00.03% of portfolio
-
S. Muoio & Co. LLC New York, NY40.7KShares$03.66% of portfolio
-
Taylor Wealth Management Partners Boston, MA27.9KShares$00.51% of portfolio
-
Wipfli Financial Advisors Llc,145Shares$00.0% of portfolio
About Global Blood Therapeutics, Inc.
- Ticker GBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,476,200
- Market Cap $4.62B
- Description
- Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...